收藏切换
SOCS3 ameliorates Parkinson’s disease neuropathology by suppressing NF-κB signaling-mediated microglial inflammation
收藏切换
Fangya ZUO1, Dan FENG1, Yun LIU1, Fenfen LIU1, Xiuhong GUO2, Yuqi LIU1, Lanlan CHEN3, Yujie WANG1, Jinyong TIAN4
Journal of Army Medical University | 2025, 47(21) : 2611 - 2620
Less
收藏切换
Journal of Army Medical University | 2025, 47(21): 2611-2620
• Neuroscience •
SOCS3 ameliorates Parkinson’s disease neuropathology by suppressing NF-κB signaling-mediated microglial inflammation
Full
Fangya ZUO1, Dan FENG1, Yun LIU1, Fenfen LIU1, Xiuhong GUO2, Yuqi LIU1, Lanlan CHEN3, Yujie WANG1, Jinyong TIAN4
Affiliations
  • 1Graduate School,Guizhou University of Traditional Chinese Medicine,Guiyang,Guizhou
  • 2Department of Critical Care Medicine,Qingzhen First People’s Hospital,Guiyang,Guizhou
  • 3Graduate School,Zunyi Medical University,Zunyi,Guizhou
  • 4Department of General Medicine,Guizhou Provincial People’s Hospital,Guiyang,Guizhou,China
Published: 2025-11-15 doi: 10.16016/j.2097-0927.202506029
Outline
收藏切换
Objective

To investigate the mechanism by which suppressor of cytokine signaling 3 (SOCS3) regulates microglial inflammation through nuclear factor-kappaB (NF-κB), providing novel mechanistic insights into microglial involvement in Parkinson’s disease (PD) pathogenesis.

Methods

① Ten male C57BL/6 mice (12 weeks old, weighing 20~25 g) were subjected to intraperitoneal injection of 15 mg/kg MPTP to establish a PD model. Rotarod test was used to assess motor function. Western blotting was employed to detect the protein expression of tyrosine hydroxylase (TH) and ionized calcium-binding adapter molecule 1 (IBA-1) in the substantia nigra. RT-qPCR was utilized to measure the mRNA level of SOCS3 in the substantia nigra. Immunohistochemistry was performed to assess NF-κB p65 subunit expression. The expression of SOCS3, NF-κB and p-NF-κB was measured with Western blotting. ② Microglial cell line BV2 was stimulated with 1 000 ng/mL lipopolysaccharide (LPS) for 6 h to establish an inflammatory model. Subsequently, SOCS3 was knocked down. NF-κB inhibitor BAY 11-7082 was used to treat the cells. RT-qPCR and Western blotting were used to measure the expression of SOCS3 at mRNA and protein levels. Western blotting was also applied to detect the expression of NF-κB and p-NF-κB, and ELISA was conducted to measure TNF-α and IL-1β levels in the culture supernatant. Immunofluorescence assay was carried out to localize NF-κB (nuclear vs cytoplasmic). ③ A co-culture system of BV2 microglia and N2a neuroblastoma cells was established to investigate the regulatory effects of microglia on neuronal cells. MTT assay and TUNEL staining were used respectively to determine cell viability and apoptosis of N2a cells.

Results

① Compared to the control mice, the PD mouse model exhibited reduced rotarod fall latency, down-regulation in TH and SOCS3(P<0.01), up-regulation in IBA-1 and increased p-NF-κB/NF-κB ratio (P<0.01). ② In BV2 cells, LPS stimulation increased TNF-α, IL-1β, and p-NF-κB/NF-κB ratio(P<0.01), while down-regulated SOCS3 expression(P<0.01). SOCS3 knockdown in LPS-stimulated BV2 cells further increased the p-NF-κB/NF-κB ratio (P<0.01), increased nuclear localization of NF-κB, and elevated TNF-α and IL-1β levels (P<0.01). BAY 11-7082 treatment in these SOCS3-knockdown, LPS-stimulated cells resulted in reduced p-NF-κB/NF-κB ratio, TNF-α, and IL-1β (P<0.01), and decreased NF-κB nuclear distribution. ③ LPS-stimulated BV2 cells reduced cell viability and increased cell apoptosis in N2a cells(P<0.01). SOCS3 knockdown in BV2 cells exacerbated the reduction in N2a cell viability (P<0.01) and the increase in cell apoptosis in N2a cells (P<0.01). BAY 11-7082 treatment of these SOCS3-knockdown BV2 microglia attenuated the reduction in N2a cell viability and decreased apoptosis in N2a cells (P<0.01).

Conclusion

SOCS3 inhibits microglia inflammatory response through down-regulation of NF-kB activity, and in turn attenuates neuronal cell death and ameliorates PD nerve injury.

Parkinson’s disease  /  microglia  /  suppressor of cytokine signaling 3  /  nuclear factor-kappa B  /  neuronal damage
左方娅, 冯丹, 刘韵, 刘纷纷, 郭修红, 刘钰淇, 陈兰兰, 王玉洁, 田锦勇. SOCS3通过抑制NF-κB信号通路介导的小胶质细胞炎症反应改善帕金森病神经损伤. 陆军军医大学学报, 2025 , 47 (21) : 2611 -2620 . DOI: 10.16016/j.2097-0927.202506029
Fangya ZUO, Dan FENG, Yun LIU, Fenfen LIU, Xiuhong GUO, Yuqi LIU, Lanlan CHEN, Yujie WANG, Jinyong TIAN. SOCS3 ameliorates Parkinson’s disease neuropathology by suppressing NF-κB signaling-mediated microglial inflammation[J]. Journal of Army Medical University, 2025 , 47 (21) : 2611 -2620 . DOI: 10.16016/j.2097-0927.202506029
Year 2025 volume 47 Issue 21
15
5
Cite this Article
BibTeX
Article Info
doi: 10.16016/j.2097-0927.202506029
  • Receive Date:2025-06-10
  • Online Date:2026-10-30
  • Published:2025-11-15
Article Data
Affiliations
History
  • Received:2025-06-10
  • Revised:2025-08-13
Affiliations
    1Graduate School,Guizhou University of Traditional Chinese Medicine,Guiyang,Guizhou
    2Department of Critical Care Medicine,Qingzhen First People’s Hospital,Guiyang,Guizhou
    3Graduate School,Zunyi Medical University,Zunyi,Guizhou
    4Department of General Medicine,Guizhou Provincial People’s Hospital,Guiyang,Guizhou,China
References
Share
https://castjournals.cast.org.cn/joweb/ljjydxxb/EN/10.16016/j.2097-0927.202506029
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT